Author name: Irma Griffin

ATR Inhibitor Berzosertib (VE-822) – A Promising Target in Cancer Therapy

Over the past few years, the area of oncology has moved to precision medicine, the ability to target particular molecular pathways that promote the growth of cancer cells. The ATR kinase (Ataxia Telangiectasia and Rad3-related protein) which is one of the major regulators of the response of the cell to DNA damage is among the […]

ATR Inhibitor Berzosertib (VE-822) – A Promising Target in Cancer Therapy Read More »

Latest
Scroll to Top